Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
Navigating advances in the myeloma landscape over the past couple of years
The ongoing debate for treating multiple myeloma
Combining CLL drugs to overcome the problem of resistance
Why use model systems for multiple myeloma research?
Enrique Ocio et al.